On March 24, Hianhe Group released its 2025 financial report. It was disclosed that the group’s revenue was RMB 14.35 billion, a year-on-year increase of 10.3%. The adjusted EBITDA profit margin was 14.3%, and the adjusted comparable net profit margin was 4.6%, a year-on-year increase of 22.7%. Among them, the Chinese market revenue reached 10.20 billion yuan, a year-on-year increase of 17.5%, accounting for 71.1% of the group's total revenue, and was the largest contributor to the group's revenue.
Adult nutrition and care products (ANC) business revenue reached 6.95 billion yuan, a year-on-year increase of 4.4%, accounting for 48.4% of the group's total revenue. Swisse's Chinese market achieved year-on-year growth of 13.3%, accounting for 70.7% of the group's ANC business sales. Swisse reaches global revenue milestone of US$1 billion in 2025. Swisse achieved double-digit revenue growth in both mainland China and overseas expansion markets.
The infant nutrition and care products (BNC) business revenue reached 5.26 billion yuan, a year-on-year increase of 20%, accounting for 36.6% of the group's total revenue. Its infant formula milk powder business achieved strong growth, and its BNC business in mainland China resumed growth. Biostime's market share in ultra-high-end infant formula milk powder reached 17.1%, a record high, and jumped to 19.5% in the last quarter of 2025. Its growth performance continues to exceed the market level. In 2025, Biostime's infant probiotic business revenue will turn around, and new children's nutritional powder products will be launched, successfully extending consumers' consumption cycles.
The pet nutrition and care products (PNC) business is an important growth engine of the group. In 2025, the overall revenue of pet nutrition and care products will reach 2.15 billion yuan, a year-on-year increase of 8.7%. Among them, high-end pet nutrition products will achieve a year-on-year growth of 14.3%, and PNC business revenue will account for 15.0% of the group's total revenue.
(Official official account of the company)
